Acute graft-versus-host disease (GVHD) following liver transplantation is a rare but fatal complication. The correct diagnosis and management of GVHD after liver transplantation are still major challenges. Herein, we reported successful salvage treatment of acute GVHD by withdrawal of immunosuppression in a patient who presented with fever, skin rashes, and decreased blood cell counts after liver transplantation. This case highlights the need for awareness of drug-induced liver injury if liver function tests are elevated during treatment, especially in patients taking multiple potentially hepatotoxic drugs, such as broad-spectrum antibiotics. When occurs, an artificial liver support system is a useful tool to provide temporary support of liver function for the patient in the event of drug-induced liver injury. 
INTRODUCTION
Acute graft-versus-host disease (GVHD), a reaction of donor immune cells against host tissues, is a frequent complication (35%-50%) after allogeneic hematopoietic stem cell transplantation. 1 In 1988, Burdick et al. 2 first described acute GVHD after orthotopic liver transplantation (OLT). However, acute GVHD after liver transplantation is rare, occurring in 0.1%-2% of patients, but a severe complication with a 85% mortality rate in adult recipients. [3] [4] [5] [6] Acute GVHD typically occurs 1-8 weeks after liver transplantation with symptoms of fever, diarrhea, and skin rashes in the early clinical course, followed by pancytopenia, sepsis, and even death. 7 Currently, the correct diagnosis and management of GVHD following liver transplantation remain major challenges. Herein, we reported a patient with acute GVHD after liver transplantation that was successfully managed by withdrawal of immunosuppression. Acute GVHD after liver transplantation On POD 28, the patient developed a fever of 38. (Fig. 2) . 8, 9 GVHD was suspected despite lack of chimerism of host-and donor-circulating lymphocytes among peripheral blood cells. 
CASE

Patient characteristics
Drug-induced liver injury
On POD 42, the patient's aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin (TBIL), and direct bilirubin (DBIL) levels were elevated to high levels (Fig. 3) . Immunosuppressive drugs, in- 
DISCUSSION
Acute GVHD following OLT is a rare but fatal complication that poses both diagnostic and therapeutic challenges. Usually, the diagnosis of acute GVHD is based on the presence of clinical manifestations and histopathological evidences. 5, 10 In the present case, the patient was readmitted 4 weeks after liver transplantation, presenting with symptoms of fever, skin rashes, decreased blood cell counts, and other typical signs of acute GVHD.
The patient was finally diagnosed with acute GVHD by skin biopsy. In addition, earlier testing for chimerism by identifying donor's HLA antigen may lead to an earlier diagnosis of GVHD. 6 The donor's HLA typing can be detected by polymerase chain reaction (PCR)-sequence-specific primers. 3, 11, 12 However, chimerism of host-and donor-circulating lymphocytes was not observed among peripheral blood cells in this case. One reason is that chimerism usually peaks in the first week, declines rapidly thereafter, and is usually absent beyond 3-4 weeks post transplantation, as reported by Taylor et al. 13, 14 Currently, most therapeutic modalities for acute GVHD are based on GVHD management after hematopoietic stem cell transplantation and focus on increasing immunosuppression. However, this treatment does not demonstrate any survival benefit. 3, 15 Thus, some investigators have proposed reducing and even completely withdrawing immunosuppression as a treatment for GVHD after liver transplantation. 3 Lehner et al. 16 reported successful salvage treatment of acute GVHD in a liver allograft recipient by withdrawal of immunosuppression; they presented evidence that withdrawal of immunosuppressive therapy al- In this case, when the patient discontinued the immunosuppressive drugs, he experienced elevations in the liver function tests. We first considered an acute rejection episode. However, the patient did not exhibit any improvement even after resuming immunosuppression. A subsequent liver biopsy helped to make a timely diagnosis of DILI. DILI is liver injury caused by various medications, leading to abnormalities in liver tests or liver dysfunction. 17 The clinical presentation of DILI is highly variable from asymptomatic, reversible elevation of liver enzymes to fulminant hepatic failure. 18 The diagnosis of DILI is difficult in patients with chronic liver disease and in those taking multiple potentially hepatotoxic drugs. 17 In this case, all drugs that might induce liver injury were immediately withdrawn from the patient at the time of diagnosis of DILI. In addition, we used artificial liver support system to provide temporary support of liver function for the patient with success.
In conclusion, withdrawal of immunosuppression may serve as an effective treatment for acute GVHD after liver transplantation. During treatment, in addition to acute rejection episodes, awareness of drug-induced liver injury is necessary if the results of liver function tests are elevated, especially for patients taking multiple potentially hepatotoxic drugs, such as broad-spectrum antibiotics.
